MRNA
Price
$24.18
Change
+$0.09 (+0.37%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
9.37B
58 days until earnings call
MRVI
Price
$2.38
Change
-$0.04 (-1.65%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
350.12M
64 days until earnings call
Interact to see
Advertisement

MRNA vs MRVI

Header iconMRNA vs MRVI Comparison
Open Charts MRNA vs MRVIBanner chart's image
Moderna
Price$24.18
Change+$0.09 (+0.37%)
Volume$269.79K
Capitalization9.37B
Maravai LifeSciences Holdings
Price$2.38
Change-$0.04 (-1.65%)
Volume$6.15K
Capitalization350.12M
MRNA vs MRVI Comparison Chart in %
Loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRNA vs. MRVI commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a Buy and MRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (MRNA: $24.09 vs. MRVI: $2.42)
Brand notoriety: MRNA: Notable vs. MRVI: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 90% vs. MRVI: 45%
Market capitalization -- MRNA: $9.41B vs. MRVI: $342.89M
MRNA [@Biotechnology] is valued at $9.41B. MRVI’s [@Biotechnology] market capitalization is $342.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 1 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • MRNA’s FA Score: 1 green, 4 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, both MRNA and MRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 4 TA indicator(s) are bullish while MRVI’s TA Score has 4 bullish TA indicator(s).

  • MRNA’s TA Score: 4 bullish, 6 bearish.
  • MRVI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both MRNA and MRVI are a bad buy in the short-term.

Price Growth

MRNA (@Biotechnology) experienced а -11.17% price change this week, while MRVI (@Biotechnology) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

MRNA is expected to report earnings on Oct 30, 2025.

MRVI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($9.37B) has a higher market cap than MRVI($350M). MRNA YTD gains are higher at: -42.063 vs. MRVI (-55.596). MRVI has higher annual earnings (EBITDA): -247.68M vs. MRNA (-2.72B). MRNA has more cash in the bank: 5.13B vs. MRVI (270M). MRVI has less debt than MRNA: MRVI (364M) vs MRNA (741M). MRNA has higher revenues than MRVI: MRNA (3.06B) vs MRVI (220M).
MRNAMRVIMRNA / MRVI
Capitalization9.37B350M2,678%
EBITDA-2.72B-247.68M1,099%
Gain YTD-42.063-55.59676%
P/E RatioN/AN/A-
Revenue3.06B220M1,389%
Total Cash5.13B270M1,900%
Total Debt741M364M204%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNAMRVI
RSI
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
78%
Advances
ODDS (%)
Bullish Trend 16 days ago
78%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
85%
Aroon
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VPTDF0.09N/A
+3.17%
VentriPoint Diagnostics Ltd.
SMFNF26.980.45
+1.70%
Sumitomo Mitsui Financial Group Inc.
CVVUF0.660.01
+1.54%
CanAlaska Uranium Ltd.
WILYY18.99N/A
N/A
Demant AS
CNHHY14.21N/A
N/A
Cairn Homes PLC

MRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNA has been loosely correlated with NVAX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNA jumps, then NVAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNA
1D Price
Change %
MRNA100%
-1.55%
NVAX - MRNA
48%
Loosely correlated
-1.45%
BNTX - MRNA
47%
Loosely correlated
-1.89%
ARCT - MRNA
46%
Loosely correlated
-1.68%
TECH - MRNA
45%
Loosely correlated
+0.55%
ALLO - MRNA
45%
Loosely correlated
-4.24%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with TECH. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
+1.68%
TECH - MRVI
46%
Loosely correlated
+0.55%
CRDF - MRVI
41%
Loosely correlated
+0.96%
FENC - MRVI
35%
Loosely correlated
N/A
MRNA - MRVI
35%
Loosely correlated
-1.55%
NRIX - MRVI
34%
Loosely correlated
-0.74%
More